Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1972 Jan;10(1):171-7.

The human secondary immune response to Keyhole limpet haemocyanin

The human secondary immune response to Keyhole limpet haemocyanin

J E Curtis et al. Clin Exp Immunol. 1972 Jan.

Abstract

The human secondary immune response to the protein antigen Keyhole limpet haemocyanin (KLH) was studied in thirteen normal adults. For secondary immunization and for measurement of delayed hypersensitivity, 100 μg of KLH was given intradermally to each individual between 81 and 375 days after primary immunization. Immunity was assessed by delayed hypersensitivity skin testing and measurement of antibody formation and KLH stimulated in vitro lymphocyte blastogenesis. Twelve of the thirteen subjects had positive KLH delayed hypersensitivity reactions. Prior to secondary immunization all thirteen had circulating lymphocytes responsive in vitro to KLH and all had circulating haemagglutinating antibody. After secondary immunization there was no further increase in the mean KLH-stimulated blastogenesis while the KLH haemagglutinin titre rose due to increased 7S antibody formation. Primary immunization with small doses of KLH was as effective in inducing immunological memory and a subsequent secondary response as immunization with large doses of the antigen.

PubMed Disclaimer

References

    1. Immunology. 1965 Oct;9(4):333-48 - PubMed
    1. J Immunol. 1965 Dec;95(6):1095-9 - PubMed
    1. J Clin Invest. 1966 Aug;45(8):1334-40 - PubMed
    1. Adv Immunol. 1966;5:1-28 - PubMed
    1. Prog Allergy. 1967;10:37-83 - PubMed

LinkOut - more resources